Zithromax Description

Film-coated Tablet 250 mg: Azithromycin film coated tablets are white to off-white, scored, modified oval film coated tablets.
Azithromycin dihydrate 262.05 mg equivalent to 250 mg azithromycin base.
Powder for Oral Suspension: Azithromycin powder for oral suspension is presented as a dry powder which yields, on reconstitution with water, from off-white to orange to brown suspension containing the equivalent of 200 mg azithromycin per 5 ml.
Azithromycin dihydrate 209.64 mg/5 ml equivalent to 200 mg/5 ml of azithromycin base.
Powder for Intravenous (IV) Solution: Azithromycin dihydrate 524.1 mg equivalent to 500 mg azithromycin base.
Azithromycin powder for solution for infusion is a white to off-white caked powder supplied in a lyophilized form under a vacuum in a 10 ml vial equivalent to 500 mg azithromycin for IV administration. Upon reconstitution, azithromycin powder yields a solution containing the equivalent of 100 mg azithromycin per 1 ml.
Excipients/Inactive Ingredients: Film-coated Tablets: The tablets contain pregelatinized starch, calcium phosphate dibasic anhydrous, croscarmellose sodium, magnesium stearate and sodium lauryl sulfate. The film coating contains hydroxypropyl methylcellulose, triacetin and titanium dioxide (E171).
Powder for Oral Suspension: The powder for oral suspension contains sucrose (1.94 g per 100 mg dose), sodium phosphate tribasic anhydrous, hydroxypropyl cellulose, xanthan gum, artificial cherry, creme de vanilla and banana flavors.
Powder for Intravenous Solution: The IV formulation contains citric acid (anhydrous) 384.6 mg, and sodium hydroxide 198.3 mg.